Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

doi:10.1016/S0264-410X(96)00058-8

Vaccine

Volume 14, Issue 14, October 1996, Pages 1331-1339

https://doi.org/10.1016/S0264-410X(96)00058-8 Get rights and content

Abstract

Three cohort studies in adults were performed during the periode from 1986 to 1989. Eight hundred and eighty-four subjects were, one or more times, immunized with influenza vaccines, and pre- and post-vaccination antibody titres were determined by hemagglutination inhibition tests. One thousand and one hundred and nineteen vaccination events in 681 subjects could be analysed by a comparison, per trial and per influenza (sub) type, between groups with and without influenza vaccination in previous years. Effect size, odds ratio and protection rate difference, were used as effect measures. Subjects with previous vaccination showed higher pre-vaccination antibody than those without. The average change of the post-vaccination proportion of subjects with high antibody titre value to previous vaccination, was +9.4% (95% CI: +5.3 to 13.6%) for A-H3N2 vaccine components, −2.1% (−8.1 to 3.9%, not significant) for A-H1N1 and −10.6% (−16.5% to −4.8%) for B. In a linear regression model, pre-vaccination titres and the status of previous vaccination were identified as factors significantly influencing post-vaccination titres. These findings are discussed in the context of a short review of the literature. It is concluded that the status of previous vaccination should always be addressed as an independent factor in serological vaccination studies.

References (30)

T.W. Hoskins et al.
Controlled trial of inactivated influenza vaccine containing the A/Hong Kong strain during an outbreak of influenza due to the A/England/42/72 strain
Lancet
(1973)
T.W. Hoskins et al.
Influenza at Christ's Hospital: March 1974
Lancet
(1976)
T.W. Hoskins et al.
Assessment of inactivated influenza A vaccine after three outbreaks of influenza at Christ's Hospital
Lancet
(1979)
T.M.E. Govaert et al.
Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial
Vaccine
(1994)
H. Glathe et al.
Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people
Vaccine
(1993)
P.A. Gross et al.
Relation of chronic disease and immune response to influenza vaccine in the elderly
Vaccine
(1989)
J.E. McElhaney et al.
Antibody response to whole-virus and split-virus influenza vaccines in successful ageing
Vaccine
(1993)
B. Berlin et al.
A method for increasing the sensitivity of the hemagglutination-inhibition test with equine influenza virus
Virology
(1963)
S. Yusuf et al.
Beta blockade during and after myocardial infarction: an overview of the randomized trials
Progr. Cardiovasc. Dis.
(1985)
W.E.P. Beyer et al.
Antibody induction by influenza vaccines in the elderly: a review of the literature
Vaccine
(1989)

A.P. Kendal et al.

Antigenic similarity of influenza A(H1N1) viruses from epidemics in 1977–1978 to “Scandinavian” strains isolated in epidemics of 1950–1951

Virology

(1978)

R. Pyhälä et al.

HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990–1992

Vaccine

(1994)

K.G. Nicholson

Annual vaccination: conclusions and recommendations

W.A. Keitel et al.

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

Am. J. Epidemiol.

(1988)

P.A. Gross et al.

Benefit of annual influenza immunization in patients with cystic fibrosis

Cited by (115)

Influenza immune escape under heterogeneous host immune histories
2021, Trends in Microbiology
In a pattern called immune imprinting, individuals gain the strongest immune protection against the influenza strains encountered earliest in life. In many recent examples, differences in early infection history can explain birth year-associated differences in susceptibility (cohort effects). Susceptibility shapes strain fitness, but without a clear conceptual model linking host susceptibility to the identity and order of past infections general conclusions on the evolutionary and epidemic implications of cohort effects are not possible. Failure to differentiate between cohort effects caused by differences in the set, rather than the order (path), of past infections is a current source of confusion. We review and refine hypotheses for path-dependent cohort effects, which include imprinting. We highlight strategies to measure their underlying causes and emergent consequences.
Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016
2021, Vaccine
Epidemiological studies suggest that influenza vaccine effectiveness decreases with repeated administration. We examined antibody responses to influenza vaccination among healthcare workers (HCWs) by prior vaccination history and determined the incidence of influenza infection.
HCWs were vaccinated with the 2016 Southern Hemisphere quadrivalent influenza vaccine. Serum samples were collected pre-vaccination, 21–28 days and 7 months post-vaccination. Influenza antibody titres were measured at each time-point using the haemagglutination inhibition (HI) assay. Immunogenicity was compared by prior vaccination history.
A total of 157 HCWs completed the study. The majority were frequently vaccinated, with only 5 reporting no prior vaccinations since 2011. Rises in titres for all vaccine strains among vaccine-naïve HCWs were significantly greater than rises observed for HCWs who received between 1 and 5 prior vaccinations (p < 0.001, respectively). Post-vaccination GMTs against influenza A but not B strains decreased as the number of prior vaccinations increased from 1 to 5. There was a significant decline in GMTs post-season for both B lineages. Sixty five (41%) HCWs reported at least one influenza-like illness episode, with 6 (4%) identified as influenza positive.
Varying serological responses to influenza vaccination were observed among HCWs by prior vaccination history, with vaccine-naïve HCWs demonstrating greater post-vaccination responses against A(H3N2).
Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people
2020, Vaccine
Through test negative designs for visiting a doctor because of influenza-like illness, many studies have found decreasing efficacy of repeated vaccination. Furthermore, waning effectiveness during interseason periods has been reported. This study was conducted to confirm negative effects of repeated vaccination in individuals with the same vaccine strain and to measure waning effects.
Our cohort includes 66 participants older than 65 years old recruited from an outpatient department of one hospital. All were vaccinated, with hemagglutination inhibition (HI) antibody titers measured from 2001/02 season through the 2003/04 season. HI antibody titers were measured three times in one season: pre-vaccination, post-vaccination, and post-epidemic. To test negative effects of immune response to the repeated vaccination, differences between protection rates and differences between response rates were analyzed for individuals in the two consecutive seasons. For the test of waning effectiveness, we measured the difference in geometric mean titers of HI antibody between post-epidemic results and pre-vaccination results obtained in the following season.
Protection rates were 40–55% in A/New Caledonia/20/99 and ≥75% in A/Panama/2007/99 by repeated vaccination. In A/New Caledonia/20/99 and A/Panama/2007/99 in the 2003/04 season, significant decreases were found in protection rates from the earlier seasons, although the rate for A/Panama/2007/99 in the 2002/03 season increased significantly from that of the prior season. The respective response rates in the 2003/04 season in A/New Caledonia/20/99, and in the 2002/03 and 2003/04 seasons in A/Panama/2007/99 decreased significantly from those of earlier seasons. Regarding waning effectiveness, antibody titers for A/New Caledonia/20/99 in 2003/04 season, and A/Panama/2007/99 in 2002/03 and 2003/04 seasons decreased significantly to 37.0–66.7%.
Results show significant negative effects of immune response by repeated vaccination and show significant waning effectiveness during the interseason for individuals with the same strain of influenza type A. The proportion of elderly people with HI antibody titers of ≥1:40 might be maintained by repeated influenza vaccination.
A novel methodology based on serological data for improving precision in the influenza vaccine response of non-seroprotected
2019, Measurement: Journal of the International Measurement Confederation
Vaccine immunogenicity trial is a widely accepted approach for estimating effects of influenza vaccine campaign since it allows reducing timing and costs with respect to clinical trials. When evaluating the influenza vaccine immunogenicity in elderly, the geometric mean of post-vaccination titers (post-GMT) of seronegatives, a population for which the pre-vaccination titer is unique and known a-priori, is the statistic that the Committee for Medical Products for Human Use (CHMP) recommends to report together with its measurement uncertainty. Since in elderly population the seronegatives represent a small fraction, this low number affects the precision of the estimate. Thus, statistical approaches that reduce significantly the corresponding measurement uncertainty are adopted.
Besides seronegatives, even the immunological response of non-seroprotected people is significant for characterizing a vaccine. However, this sub-population includes people with more than one single pre-vaccination state, and thus the statistical methodology usually applied to seronegatives for improving the estimate precision cannot be applied automatically. In this paper, a novel approach is described for improving the precision of post-GMT estimate from serological data of non-seroprotected elderly, a population for which the influenza vaccination is strongly recommended by CHMP. The precision of the proposed methodology is characterized in terms of type-A uncertainty on elderly Umbrian (Italian) population and results confirm its effectiveness. Due to the increased precision of the obtained post-GMT estimate, also the quality of comparative studies, that otherwise could be highly affected by the choice of evaluating vaccine effects based on serological parameters, improves with respect to the use of standard methods indicated in the scientific literature.
Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine
2018, Vaccine
Citation Excerpt :
As there are frequent antigenic changes in the HA of seasonal influenza viruses and exposure to more variant influenza antigens can confer broader protection [7], it is important to understand how pre-existing immunity influences the response to changing influenza virus strains. There have been reports that pre-existing immunity negatively influences vaccination responses [8–10]. Here, we investigated the extent to which pre-existing antibodies influenced the cross-reactive antibody response to pandemic H1N1 vaccination in healthcare workers.
The 2009 pandemic H1N1 (A(H1N1)pdm09) virus had a highly divergent hemagglutinin (HA) compared to pre-2009 seasonal H1N1 strains. Most peoples were immunologically naïve to the A(H1N1)pdm09, although hospital workers were exposed early in the pandemic before pandemic vaccines became available. Here, we evaluated how pre-existing antibodies influence the induction of cross-functional HA stalk antibodies following A(H1N1)pdm09 vaccination.
Fifty-six healthcare workers vaccinated with AS03 adjuvanted A(H1N1)pdm09 vaccine were chosen by their pre-vaccination priming status (primed HI titers ≥ 40 or unprimed < 40). We analyzed the HA head- and stalk-specific serum IgG subclasses at pre- and 21 days post-vaccination. We also assessed the functionality of the HA stalk-specific antibodies to neutralize virus and mediate antibody dependent cellular cytotoxicity (ADCC).
Primed individuals had higher pre-existing HA head- and stalk-specific IgG1, as well as higher ADCC functionality of stalk antibodies. However, following vaccination with the adjuvanted pandemic vaccine, only the quantity of HA head specific IgG1 antibodies were significantly higher than in unprimed individuals. The priming status did not impact upon the cross-reactive HA stalk specific IgG antibodies or their ability to neutralize virus or induce ADCC post-vaccination. In conclusion, a single dose of AS03 adjuvanted pandemic vaccine elicited similar levels of functional antibodies in naïve and primed individuals. These findings are important for understanding the immunological factors that impact or modulate pandemic vaccine responses in humans.
Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns
2017, Vaccine
Citation Excerpt :
However, rates of clinically confirmed influenza infection were not examined in this study. As reviewed, attenuated immunological responses have been demonstrated in several studies in relation to repeated vaccination [23,52,53]. Corresponding impairment in vaccine efficacy (as defined by rates of clinical infection), while observed in some studies [54], have not consistently been reported [55,56].
In the US, influenza vaccination is recommended annually to everyone ≥6 months. Prior receipt of influenza vaccine can dampen antibody responses to subsequent vaccination. This may have implications for pregnant women and their newborns, groups at high risk for complications from influenza infection.
This study examined effects of prior vaccination on maternal and cord blood antibody levels in a cohort of pregnant women in the US.
Influenza antibody titers were measured in 141 pregnant women via the hemagglutination inhibition (HAI) assay prior to receipt of quadrivalent influenza vaccine, 30 days post-vaccination, and at delivery (maternal and cord blood). Logistic regression analyses adjusting for age, BMI, parity, gestational age at vaccination, and year of vaccination compared HAI titers, seroprotection, and seroconversion in women with versus without vaccination in the prior year.
Compared to those without vaccination in the previous year (n = 50), women with prior vaccination (n = 91) exhibited higher baseline antibody titers and/or seroprotection rates against all four strains after controlling for covariates. Prior vaccination also predicted lower antibody responses and seroconversion rates at one month post-vaccination. However, at delivery, there were no significant differences in antibody titers or seroprotection rates in women or newborns, and no meaningful differences in the efficiency of antibody transfer, as indicated by the ratio of cord blood to maternal antibody titers at the time of delivery.
In this cohort of pregnant women, receipt of influenza vaccine the previous year predicted higher baseline antibody titers and decreased antibody responses at one month post-vaccination against all influenza strains. However, prior maternal vaccination did not significantly affect either maternal antibody levels at delivery or antibody levels transferred to the neonate. This study is registered with the NIH as a clinical trial (NCT02148874).

View all citing articles on Scopus

View full text

PaperEffects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

Abstract

Lancet

Lancet

Lancet

Vaccine

Vaccine

Vaccine

Vaccine

Virology

Progr. Cardiovasc. Dis.

Vaccine

Virology

Vaccine

Annual vaccination: conclusions and recommendations

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

Am. J. Epidemiol.

Benefit of annual influenza immunization in patients with cystic fibrosis

Paper
Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults